246 related articles for article (PubMed ID: 24140546)
41. Self-assembled core-shell vascular-targeted nanocapsules for temporal antivasculature and anticancer activities.
Wang Z; Ho PC
Small; 2010 Nov; 6(22):2576-83. PubMed ID: 20976704
[TBL] [Abstract][Full Text] [Related]
42. Tumour targeting of lipid nanocapsules grafted with cRGD peptides.
Hirsjärvi S; Belloche C; Hindré F; Garcion E; Benoit JP
Eur J Pharm Biopharm; 2014 May; 87(1):152-9. PubMed ID: 24361535
[TBL] [Abstract][Full Text] [Related]
43. Magnetically Targeted Nanocapsules for PAA-Cisplatin-Conjugated Cores in PVA/SPIO Shells via Surfactant-Free Emulsion for Reduced Nephrotoxicity and Enhanced Lung Cancer Therapy.
Chiang CS; Tseng YH; Liao BJ; Chen SY
Adv Healthc Mater; 2015 May; 4(7):1066-75. PubMed ID: 25656800
[TBL] [Abstract][Full Text] [Related]
44. Lipid nanocapsules for intracellular drug delivery of anticancer drugs.
Lacoeuille F; Garcion E; Benoit JP; Lamprecht A
J Nanosci Nanotechnol; 2007 Dec; 7(12):4612-7. PubMed ID: 18283853
[TBL] [Abstract][Full Text] [Related]
45. siRNA LNCs--a novel platform of lipid nanocapsules for systemic siRNA administration.
David S; Resnier P; Guillot A; Pitard B; Benoit JP; Passirani C
Eur J Pharm Biopharm; 2012 Jun; 81(2):448-52. PubMed ID: 22381204
[TBL] [Abstract][Full Text] [Related]
46. Curcumin-loaded lipid-core nanocapsules as a strategy to improve pharmacological efficacy of curcumin in glioma treatment.
Zanotto-Filho A; Coradini K; Braganhol E; Schröder R; de Oliveira CM; Simões-Pires A; Battastini AM; Pohlmann AR; Guterres SS; Forcelini CM; Beck RC; Moreira JC
Eur J Pharm Biopharm; 2013 Feb; 83(2):156-67. PubMed ID: 23219677
[TBL] [Abstract][Full Text] [Related]
47. Highly efficient and lowly toxic docetaxel nanoemulsions for intravenous injection to animals.
Li X; Du L; Wang C; Liu Y; Mei X; Jin Y
Pharmazie; 2011 Jul; 66(7):479-83. PubMed ID: 21812321
[TBL] [Abstract][Full Text] [Related]
48. Polymeric nanocarriers for magnetic targeted drug delivery: preparation, characterization, and in vitro and in vivo evaluation.
Licciardi M; Scialabba C; Fiorica C; Cavallaro G; Cassata G; Giammona G
Mol Pharm; 2013 Dec; 10(12):4397-407. PubMed ID: 24168360
[TBL] [Abstract][Full Text] [Related]
49. Selective tissue distribution and long circulation endowed by paclitaxel loaded PEGylated poly(ε-caprolactone-co-L-lactide) micelles leading to improved anti-tumor effects and low systematic toxicity.
Wang F; Shen Y; Xu X; Lv L; Li Y; Liu J; Li M; Guo A; Guo S; Jin F
Int J Pharm; 2013 Nov; 456(1):101-12. PubMed ID: 23968782
[TBL] [Abstract][Full Text] [Related]
50. N-octyl-O-sulfate chitosan-modified liposomes for delivery of docetaxel: preparation, characterization, and pharmacokinetics.
Qu G; Wu X; Yin L; Zhang C
Biomed Pharmacother; 2012 Feb; 66(1):46-51. PubMed ID: 22264883
[TBL] [Abstract][Full Text] [Related]
51. In vivo delivery of silica nanorattle encapsulated docetaxel for liver cancer therapy with low toxicity and high efficacy.
Li L; Tang F; Liu H; Liu T; Hao N; Chen D; Teng X; He J
ACS Nano; 2010 Nov; 4(11):6874-82. PubMed ID: 20973487
[TBL] [Abstract][Full Text] [Related]
52. Aqueous-core PEG-coated PLA nanocapsules for an efficient entrapment of water soluble anticancer drugs and a smart therapeutic response.
Cosco D; Paolino D; De Angelis F; Cilurzo F; Celia C; Di Marzio L; Russo D; Tsapis N; Fattal E; Fresta M
Eur J Pharm Biopharm; 2015 Jan; 89():30-9. PubMed ID: 25460850
[TBL] [Abstract][Full Text] [Related]
53. Role of the templating approach in influencing the suitability of polymeric nanocapsules for drug delivery: LbL vs SC/MS.
Goethals EC; Shukla R; Mistry V; Bhargava SK; Bansal V
Langmuir; 2013 Oct; 29(39):12212-9. PubMed ID: 23998648
[TBL] [Abstract][Full Text] [Related]
54. Biodegradable core-shell nanoassemblies for the delivery of docetaxel and Zn(II)-phthalocyanine inspired by combination therapy for cancer.
Conte C; Ungaro F; Maglio G; Tirino P; Siracusano G; Sciortino MT; Leone N; Palma G; Barbieri A; Arra C; Mazzaglia A; Quaglia F
J Control Release; 2013 Apr; 167(1):40-52. PubMed ID: 23298613
[TBL] [Abstract][Full Text] [Related]
55. Novel Gellan Gum-Based In Situ Nanovesicle Formulation of Docetaxel for Its Localized Delivery Using Depot Formation.
Singh A; Thakur S; Singh N; Kaur S; Jain SK
AAPS PharmSciTech; 2021 May; 22(5):165. PubMed ID: 34046797
[TBL] [Abstract][Full Text] [Related]
56. Optimization of (1,2-diamino-cyclohexane)platinum(II)-loaded polymeric micelles directed to improved tumor targeting and enhanced antitumor activity.
Cabral H; Nishiyama N; Kataoka K
J Control Release; 2007 Aug; 121(3):146-55. PubMed ID: 17628162
[TBL] [Abstract][Full Text] [Related]
57. Tumor-targeting peptide conjugated pH-responsive micelles as a potential drug carrier for cancer therapy.
Wu XL; Kim JH; Koo H; Bae SM; Shin H; Kim MS; Lee BH; Park RW; Kim IS; Choi K; Kwon IC; Kim K; Lee DS
Bioconjug Chem; 2010 Feb; 21(2):208-13. PubMed ID: 20073455
[TBL] [Abstract][Full Text] [Related]
58. Gold nanocluster-conjugated amphiphilic block copolymer for tumor-targeted drug delivery.
Chen T; Xu S; Zhao T; Zhu L; Wei D; Li Y; Zhang H; Zhao C
ACS Appl Mater Interfaces; 2012 Nov; 4(11):5766-74. PubMed ID: 23043448
[TBL] [Abstract][Full Text] [Related]
59. Poly(N-vinylpyrrolidone)-block-poly(D,L-lactide) as a new polymeric solubilizer for hydrophobic anticancer drugs: in vitro and in vivo evaluation.
Le Garrec D; Gori S; Luo L; Lessard D; Smith DC; Yessine MA; Ranger M; Leroux JC
J Control Release; 2004 Sep; 99(1):83-101. PubMed ID: 15342183
[TBL] [Abstract][Full Text] [Related]
60. A novel lactoferrin-modified β-cyclodextrin nanocarrier for brain-targeting drug delivery.
Ye Y; Sun Y; Zhao H; Lan M; Gao F; Song C; Lou K; Li H; Wang W
Int J Pharm; 2013 Dec; 458(1):110-7. PubMed ID: 24126038
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
